InvestorsHub Logo
Followers 14
Posts 249
Boards Moderated 0
Alias Born 06/09/2015

Re: None

Thursday, 11/05/2015 10:48:25 AM

Thursday, November 05, 2015 10:48:25 AM

Post# of 1396
MEIP "Overall Survival Not Yet Arrived" is GOOD!

They are talking about MEDIAN survival. Anyone who took a statistics class in school knows that a median is the middle number within a series. So in this case, people are surviving so long that the median has simply not yet arrived.

Remember, the AML trial began recruiting exactly 12 months ago. So 12 months worth of data is all they have right now. Their goal is to show that OS is greater than 12 months, as that would be significantly higher than Azacitidine alone and would justify moving forward with their combo therapy. Again, if OS was low, they would have arrived at the median already... but it's been so good that it's going to take longer to arrive at the median! Once data is presented in December, they will show that OS is much greater than 12 months, and further data in early Q1 will continue to show how much higher it is.

So don't worry about how the market is reacting right now. It could be tutes and/or MM's playing games, it could be shorts taking advantage of the recent spike, or it could be retail reacting to a poor choice of words within the abstract. Bottom line is, the data was fantastic, and eventually the price will reflect it.

I am not selling now. What's the point? Worst-case downside is MAYBE going back to $1.70, but I doubt it. I'm not gonna flip my shares here to try and buy back 20 cents cheaper... because the second I do that she's gonna break through $2.20 and start running to $3.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MEIP News